Home > Boards > US OTC > Biotechs > Neuralstem Inc. (CUR)

Put your head back on your shoulder and

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
biomanbaba Member Profile
 Grandfathered Member
Followed By 231
Posts 14,251
Boards Moderated 1
Alias Born 02/04/01
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/1/2014 4:34:07 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/30/2014 4:01:46 PM
Neuralstem Added To Russell 3000 Index "PR Newswire (US)" - 6/30/2014 9:15:00 AM
Neuralstem's NSI-189 Novel Neurogenic Compound Shows Significant Effect In Major Depressive Disorder "PR Newswire (US)" - 6/25/2014 9:15:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 6/20/2014 6:01:56 AM
Neuralstem NSI-189 Select Data To Be Presented At Neuropsychopharmacology Congress "PR Newswire (US)" - 6/19/2014 9:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/18/2014 4:06:16 PM
Neuralstem Final Phase I Depression Data Presented At The American Society Of Clinical Psychopharmacology Annual Meeting "PR Newswire (US)" - 6/18/2014 9:15:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/11/2014 4:25:03 PM
Securities Registration Statement (simplified Form) (s-3) "Edgar (US Regulatory)" - 6/6/2014 4:04:58 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 6/2/2014 4:24:23 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/2/2014 4:01:57 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/23/2014 4:05:55 PM
Neuralstem Depression Trial Data to Be Presented at The American Society of Clinical Psychopharmacology Annual Meeting "PR Newswire (US)" - 5/23/2014 9:28:00 AM
Neuralstem CEO, Richard Garr, to Present at World Stem Cells & Regenerative Medicine Congress and Give Update on Trials "PR Newswire (US)" - 5/16/2014 9:15:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/12/2014 4:09:50 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/12/2014 4:03:55 PM
Neuralstem Reports First Quarter Financial Results And Provides Business And Clinical Update "PR Newswire (US)" - 5/12/2014 9:15:00 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/12/2014 6:26:31 AM
Neuralstem Appoints Sandford Drexel Smith, Former Genzyme Executive Vice President, To Board Of Directors "PR Newswire (US)" - 5/8/2014 9:15:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 5/7/2014 5:30:55 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/23/2014 4:04:27 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) "Edgar (US Regulatory)" - 4/18/2014 4:01:06 PM
Neuralstem Spinal Cord Injury Stem Cell Trial Approved To Commence At University Of California, San Diego "PR Newswire (US)" - 4/16/2014 9:15:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/11/2014 4:18:55 PM
biomanbaba  Grandfathered Member Tuesday, 10/08/13 08:26:29 PM
Re: situps00 post# 1270
Post # of 2948 
Put your head back on your shoulder and use it for thinking

I am writing this to you now situps because it will become one of my most famous posts when I write my book in 2019. You are now part of the LEGEND

Forget the noise my friend and GO visit APRIL
http://thealsexpress.com/stem-cell-study/
This wonderful young woman is going to tell us IN REAL TIME how the most important Clinical Trial ever conducted in ALS is going.
Her progress and her blog are going to force the shorts here to beat their swords into plowshares and praise God.

These shares will be $10 by Christmass of 2013 and shareholders will have a Merry one. 2.20s are cheaper than dirt...load them
Who told you that?

T H E BIOMANBABA

Take your basis off on ANY run
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist